Please login to read the full article.
Scrip Regulatory Affairs
New guidance from the US FDA may mean just one thing for medical device manufacturers - more 510(k)s
01 August 2011
Jennifer D Newberger
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Industry expresses concern over US FDA guideline on device changes needing new 510(k)s
- US FDA invites feedback on IOM advice to scrap 510(k) process
- IOM report recommends abandoning US FDA 510(k) process in favour of new framework; industry concerned
- US FDA device reviewers to use new worksheet from 1 May to capture benefit-risk determinations
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
